| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.15 | 0.5 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.5 |